In this pivot episode, James Winterman, Vice President of Scientific Marketing at Caris Life Sciences, joins Chadi as a citizen of England to discuss and reflect on the passing of the late Queen Elizabeth II. He begins with a condensed history lesson of the United Kingdom, how the healthcare system differs slightly across the UK and how it compares to that of the US, and where government power rests. Then, he delves into the royal family and their position in all of this. What social and political roles do individuals in the royal family have? How and why does the royal family bring the people of England together? James answers these questions and more, along with a detailed explanation of how the Queen has had a more profound impact on his life than he had known before her passing.
N/A
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
